Drug intelligence / Profile preview

anti-FR4

Development stage
Preclinical
Lead developer
BioLegend
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**anti-FR4** is a monoclonal antibody that targets Folate Receptor 4 (FR4), a cell surface protein predominantly expressed on murine regulatory T cells (Tregs) and certain subsets of CD4+ T cells. It is primarily used as a research tool to deplete FR4-expressing cells in murine immunology and transplantation models[1][2][3][7]. Depletion of FR4+ cells with anti-FR4 antibodies modulates immune tolerance and rejection—anti-FR4 has been shown to ablateg CD4+FR4+ cells, affecting the balance of immune response, particularly in transplantation and tolerance disruption scenarios[1]. This antibody is not approved for human therapeutic use and is mainly employed in preclinical mouse studies[1][2][3][7].

Other names
anti-mouse FR4 antibodyanti-Folate Receptor 4 antibody
02

Targets

FR4 (Sperm-egg fusion protein Juno)

Beyond the preview

Go deeper on anti-FR4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-FR4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call